Abstract
Australia Wound Care Management Medical Equipment Industry Report
Summary
This report is an essential source for in-depth information and data relating
to Australia wound care management medical equipment market. It also offers
detailed and comprehensive coverage of market revenue, volume, distribution
and company share information; and latest news, financial deals and pipeline
products information of each of the key sub-segments of thewound care
management in Australia
Scope
・ The report provides sector information broken down into detailed categories
and segments in country.
・ Total revenues, products sold, end users, and
average pricing.
・ Market shares of all the key competitors.
・ Key
pipeline products that are set to shape the market, broken down by sector.
・ Information on the top medical equipment companies in the sector in the
country covering business description, strategic analysis, and financial
information.
・ Healthcare structure, regulatory environment, approval
process, pricing trends and reimbursement.
・ Product and brand updates,
strategy changes, R&D projects, corporate expansions and contractions and
regulatory changes.
・ Key mergers and acquisitions, partnerships, private
equity investments and IPOs.
・ Customer, hospitals and physicians
data.
Reasons to buy
・ Gain a strong understanding of the industry at a global level, with break
downs for the country
・ Evaluate and compare the attractiveness of the
market in the country.
・ Identify growth segments and opportunities in
each industry sector within the country.
・ Evaluate the pipeline of key
products that will change the sector, and identify threats and opportunities
before the products are launched in the country.
・ Analyze the
competitiveness of the market in the country and identify hotspots.
・
Develop strategies based on the latest product, brand, expansion and research
and development news in the country.
・ Do deals with an understanding of
how competitors are financed, and the mergers and partnerships that have
shaped the market in the country.
・ Identify and analyze the strengths and
weaknesses of the industry incumbents in the country.
Table of Contents
Table of Contents
1 Table of Contents 2
1.1 List of Tables 13
1.2 List of Figures 17
2 Introduction 20
2.1 What Is This Report
About? 20
2.2 Definitions 20
2.2.1 Wound Care Management 20
2.2.1.1 Traditional Wound Management 20
2.2.1.2 Advanced Wound Management
20
2.2.1.3 Wound Closure Devices 20
2.2.1.4 Ostomy 21
2.2.1.5
Compression Therapy 21
3 Healthcare Sector Review 22
3.1 Healthcare
Expenditure 22
3.2 Healthcare Infrastructure 25
3.3 Healthcare Policy
28
4 Wound Care Management in Australia 30
4.1 Wound Care Management
Overall Revenues (2000-2012) 30
4.2 Wound Care Management Overall Volume
(2000-2012) 36
4.3 Wound Care Management Overall Company Shares
(2005-2006) 39
5 Wound Closure Devices in Australia 40
5.1 Wound
Closure Devices Overall Revenues (2000-2012) 40
5.1.1 Skin Closure Devices
Overall Revenues (2000-2012) 44
5.1.2 Hemostats Overall Revenues
(2000-2012) 46
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 48
5.2 Wound Closure Devices Overall Volume (2000-2012) 50
5.2.1 Skin Closure
Devices Overall Volume (2000-2012) 52
5.2.2 Hemostats Overall Volume
(2000-2012) 54
5.2.3 Tissue Sealants Overall Volume (2000-2012) 56
5.3
Wound Closure Devices Average Price (2000-2012) 58
5.3.1 Hemostats Average
Price (2000-2012) 58
5.3.2 Tissue Sealants Average Price (2000-2012)
60
5.3.3 Skin Closure Devices Average Price (2000-2012) 62
5.4 Wound
Closure Devices Distribution Share (2005-2006) 64
5.5 Wound Closure
Devices Company Share (2005-2006) 65
6 Ostomy in Australia 66
6.1
Ostomy Overall Revenue (2000-2012) 66
6.2 Ostomy Overall Volume
(2000-2012) 68
6.3 Ostomy Average Price (2000-2012) 70
6.4 Ostomy
Distribution Share (2005-2006) 72
6.5 Ostomy Company Share (2005-2006)
73
7 Advanced Wound Management in Australia 74
7.1 Advanced Wound
Management Overall Revenue (2000-2012) 74
7.2 Advanced Wound Management
Overall Volume (2000-2012) 76
7.3 Advanced Wound Management Average Price
(2000-2012) 78
7.4 Advanced Wound Management Distribution Share
(2005-2006) 80
7.5 Advanced Wound Management Company Share (2005-2006)
81
8 Traditional Wound Management in Australia 82
8.1 Traditional
Wound Management Overall Revenue (2000-2012) 82
8.2 Traditional Wound
Management Overall Volume (2000-2012) 84
8.3 Traditional Wound Management
Average Price (2000-2012) 86
8.4 Traditional Wound Management Distribution
Share (2005-2006) 88
8.5 Traditional Wound Management Company Share
(2005-2006) 89
9 Compression Therapy in Australia 90
9.1 Compression
Therapy Overall Revenue (2000-2012) 90
9.2 Compression Therapy Overall
Volume (2000-2012) 92
9.3 Compression Therapy Average Price (2000-2012)
94
9.4 Compression Therapy Distribution Share (2005-2006) 96
9.5
Compression Therapy Company Share (2005-2006) 97
10 Covidien Ltd./Tyco
Healthcare Company Profile 98
10.1 Company Overview 98
10.2 Business
Overview 98
10.2.1 Imaging Solutions 98
10.2.2 Medical Devices 99
10.2.3 Medical Supplies 99
10.2.4 Pharmaceutical Products 100
10.2.5
Retail Products 100
10.2.6 Products 101
10.2.7 History 102
10.3
Value Chain Analysis 103
10.3.1 Manufacturing 104
10.3.2 Product
Development 104
10.3.3 Sales and Marketing 105
10.4 SWOT Analysis
106
10.4.1 Covidien Ltd./Tyco Healthcare Strengths 106
10.4.2 Covidien
Ltd./Tyco Healthcare Weaknesses 107
10.4.3 Covidien Ltd./Tyco Healthcare
Opportunities 108
10.4.4 Covidien Ltd./Tyco Healthcare Threats 109
10.5 Financial and Operational Review 110
10.5.1 Financial Statements
110
10.5.2 Financial Ratios 111
10.6 Locations And Subsidiaries
112
10.7 Financial Deals Landscape 114
10.7.1 Covidien Signs An
Agreement With Allergan 114
10.7.2 Covidien Acquires Scandius Biomedical
115
10.7.3 Covidien International Finance Completes Private Placement Of
$2,750 Million 117
10.7.4 Covidien And BioSynthema Enter Into Licensing
Agreement 118
10.7.5 Integra LifeSciences Acquires Assets Of Radionics
Division From Covidien 120
10.7.6 Covidien To Sell European Incontinence
Business 122
10.7.7 Covidien To Acquire Tissue Science Laboratories
123
10.8 Recent Developments 126
10.8.1 Mar 28, 2008: Covidien Spends
$760,000 Lobbying Federal Government In 2007 126
10.8.2 Mar 18, 2008:
Covidien Declares Quarterly Dividend 126
10.8.3 Feb 21, 2008: Covidien
Gests Favorable Decision In Patent Litigation Case 126
10.8.4 Feb 07,
2008: Covidien Declares Q1 Fiscal 2008 Results 127
10.8.5 Jan 15, 2008:
Covidien Declares Quarterly Dividend 128
10.8.6 Jan 10, 2008: Covidien To
Declare Q1 Fiscal 2008 Results 129
10.8.7 Dec 06, 2007: Covidien Reports
Q4 Fiscal 2007 Results 129
10.8.8 Oct 04, 2007: Covidien And NewSouth
Innovations Collaborate To Develop Novel Imaging Agent 131
10.8.9 Sep
28, 2007: Covidien Declares Quarterly Dividend 131
10.8.10 Aug 09, 2007:
Covidien Declares Q3 Fiscal 2007 Results 131
10.9 Covidien Ltd./Tyco
Healthcare Pipeline Products 133
10.9.1 PleuraSeal Lung Sealant System
133
10.9.1.1 Product Overview 133
10.9.1.2 Product Description 133
10.9.1.3 Product Status 133
10.9.1.4 Product Milestone 133
10.9.2
Sandman Intro CPAP Device 134
10.9.2.1 Product Overview 134
10.9.2.2
Product Description 134
10.9.2.3 Product Status 134
10.9.2.4 Product
Milestone 134
11 3M Company Profile 136
11.1 Company Overview 136
11.2 Business Overview 136
11.2.1 Consumer and Office 136
11.2.2
Display and Graphics 136
11.2.3 Electro and Communications 137
11.2.4
Health Care 138
11.2.5 Industrial and Transportation 138
11.2.6
Safety, Security and Protection Services 139
11.2.7 Products 140
11.3
Value Chain Analysis 142
11.3.1 Manufacturing 142
11.3.2 Product
Development 142
11.3.3 Sales and Marketing 143
11.4 SWOT Analysis
144
11.4.1 3M Company Strengths 144
3M Company Weaknesses 145
3M
Company Opportunities 145
3M Company Threats 146
11.5 Financial and
Operational Review 147
11.6 Locations And Subsidiaries 148
11.7
Financial Deals Landscape 150
11.7.1 3M Canada Acquires Les Entreprises
Solumed 150
11.7.2 3M Acquires Bondo 152
11.7.3 3M Acquires
Lingualcare 154
11.7.4 3M Acquires Abzil Industria E Comercio 156
11.7.5 3M Acquires Neo Plast 158
11.7.6 3M Acquires Assets Of DMS Chile
160
11.7.7 3M Acquires Business Of Innovative Paper Technologies 162
11.7.8 3M Acquires Powell 164
11.7.9 Gen-Probe Signs An Agreement With 3M
Company 166
11.7.10 3M Acquires Acolyte Biomedica 168
11.7.11 3M
Acquires Sealed Air Corp.' S Interest In Polymask Corp. 170
11.7.12 3M
Sells Its Pharmaceutical Business To Meda AB 172
11.7.13 3M Acquires
SoftMed Systems 174
11.7.14 3M Sells its Pharmaceuticals Business to
Graceway 177
11.7.15 Gen-Probe Signs An Agreement With 3M 179
11.7.16
3M Sells its Pharmaceutical Operations in the Asia Pacific Region to
Ironbridge Capital and Archer Capital 181
11.7.17 3M Acquires Biotrace
International 183
11.7.18 Ekahau Secures $16 Million In Additional Funding
185
11.7.19 3M Acquires Brontes Technologies 188
11.7.20 3M acquires
Nylonge Corp 190
11.7.21 3M Signs An Agreement With ClozeX Medical 192
11.7.22 3M Acquires OMNII Oral Pharmaceuticals 194
11.7.23 3M Sells
Pharmaceutical Operations In The United States To Graceway 196
11.7.24 3M
Sells Pharmaceutical Business In Europe To Meda AB 199
11.7.25 3M Sells
Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer
Capital 202
11.7.26 3M Acquires Accuspray Application Technologies Inc.
205
11.7.27 3M to acquire Rochford Thompson Equipment 206
11.7.28 3M
To Acquire Aearo Technologies From Permira 209
11.7.29 Permira To Sell
Aearo Technologies To 3M 211
11.8 Recent Developments 214
11.8.1 Mar
31, 2008: HighJump Software Introduces Survey Management Solution for Direct
Store Delivery Businesses 214
11.8.2 Mar 24, 2008: Brazil' s Companhia de
Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line
Over Parana River in Sao Paulo State 214
11.8.3 Mar 19, 2008: 3M to
Headquarter Optical Systems Business in Asia 216
11.8.4 Mar 19, 2008: 3M
To Headquarter Optical Systems Business In North Asia 216
11.8.5 Feb 11,
2008: 3M Increases Dividend for the 50th Straight Year 216
11.8.6 Nov 12,
2007: 3M Declares Quarterly Dividend 216
11.8.7 Oct 24, 2007: 3M And Sanyo
Settle Suit On Lithium Ion Battery 216
11.8.8 Aug 13, 2007: 3M Declares
Quarterly Dividend 217
11.8.9 May 08, 2007: 3M Declares Quarterly Dividend
217
11.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid
Molecular Tests 217
12 Smith & Nephew Plc Company Profile 218
12.1
Company Overview 218
12.2 Business Overview 218
12.2.1 Advanced Wound
Management 218
12.2.2 Endoscopy 219
12.2.3 Reconstruction 219
12.2.4 Trauma and Clinical Therapies 220
12.2.5 Products 221
12.2.6
History 221
12.3 Value Chain Analysis 225
12.3.1 Manufacturing 225
12.3.2 Product Development 226
12.3.3 Sales and Marketing 227
12.4
SWOT Analysis 228
12.4.1 Smith & Nephew Plc Strengths 228
12.4.2 Smith
& Nephew Plc Weaknesses 229
12.4.3 Smith & Nephew Plc Opportunities
229
12.4.4 Smith & Nephew Plc Threats 230
12.5 Financial and
Operational Review 231
12.6 Locations And Subsidiaries 232
12.7
Financial Deals Landscape 234
12.7.1 Smith & Nephew Endoscopy Sells Its
Vascular Business To InaVein 234
12.7.2 Smith & Nephew Signs An Agreement
With Universal Hospital Services 234
12.7.3 Smith & Nephew Acquires Plus
Orthopedics Holding 235
12.7.4 Smith & Nephew And Teknimed Enter Into
Distribution Agreement 237
12.7.5 Smith & Nephew Acquires BlueSky Medical
Group 238
12.7.6 Smith & Nephew Enters Into An Agreement With Covalon
239
12.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories 240
12.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew 241
12.7.9
Smith & Nephew Acquires Osteobiologics 242
12.7.10 Smith & Nephew And
Q-MED Enter Into Licensing Agreement 243
12.7.11 Smith & Nephew Completes
Sale Of 50% Interest In BSN Medical To Montagu Private Equity 244
12.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew 245
12.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research
Technologies 246
12.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft
247
12.7.15 Osteotech And Smith & Nephew Enter Into Processing And
Distribution Agreement 248
12.7.16 Smith & Nephew Acquires VERSAJET From
HydroCision 249
12.7.17 Smith & Nephew Terminates Acquisition Of Biomet
250
12.8 Recent Developments 252
12.8.1 Apr 02, 2008: Smith & Nephew
Declares Second Interim Dividend 252
12.8.2 Apr 02, 2008: Smith & Nephew
Reports 2007 Results 252
12.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle
To Win Over America' s Hip Generation 253
12.8.4 Feb 29, 2008: Smith &
Nephew Appoints SVP, GM 254
12.8.5 Feb 20, 2008: Smith & Nephew and
Synthes Settle Patent Dispute For Trochanteric Fixation Nails 255
12.8.6
Oct 22, 2007: Smith & Nephew Declares Interim Dividend 255
12.8.7 May 03,
2007: Smith & Nephew Appoints New CEO 255
12.9 Smith & Nephew Plc Pipeline
Products 257
12.9.1 R3 Modular resurfacing Acetabular system 257
12.9.1.1 Product Overview 257
12.9.1.2 Product Description 257
12.9.1.3 Product Status 257
12.9.2 R3 Ceramic-on-ceramic Acetabular System
257
12.9.2.1 Product Overview 257
12.9.2.2 Product Description 257
12.9.2.3 Product Status 257
13 Baxter International Company Profile
258
13.1 Company Overview 258
13.2 Business Overview 258
13.2.1
BioScience 258
13.2.2 Medication Delivery 258
13.2.3 Renal 259
13.2.4 Products 259
13.2.5 History 260
13.3 Value Chain Analysis
263
13.3.1 Manufacturing 263
13.3.2 Product Development 264
13.3.3
Sales and Marketing 264
13.4 SWOT Analysis 265
13.4.1 Baxter
International Inc. Strengths 265
13.4.2 Baxter International Inc.
Weaknesses 266
13.4.3 Baxter International Inc. Opportunities 266
13.4.4 Baxter International Inc. Threats 267
13.5 Financial and
Operational Review 268
13.6 Locations And Subsidiaries 270
13.7
Financial Deals Landscape 272
13.7.1 Baiyunshan And Baxter Form A Joint
Venture In China 272
13.7.2 Baxter Signs Licensing Agreement With
Intercytex And Spinal Restoration 273
13.7.3 Baxter Sells Transfusion
Therapies Business to Texas Pacific and Maverick Capital 275
13.7.4 B.
Braun Acquires Renal Therapy Business Of Baxter 277
13.7.5 Innovata signs
a license agreement with Baxter International 278
13.7.6 Kuros Biosurgery
Signs An Agreement With Baxter International 280
13.7.7 Gambro Signs An
Agreement With Baxter 282
13.7.8 Baxter Healthcare And Gambro Enter Into
An Agreement 283
13.7.9 Baxter and Cerus Enter Into Agreement With BioOne
for Commercialization Of INTERCEPT Blood System 285
13.7.10 Baxter
International And Kaketsuken Enter Into Agreement 287
13.7.11 Baxter To
Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful 288
13.8
Recent Developments 289
13.8.1 Jan 24, 2008: Baxter Achieves Record Sales
and Earnings for Full-Year 2007 289
13.8.2 Dec 18, 2007: Baxter Elects CFO
291
13.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend 291
13.8.4
Aug 01, 2007: Baxter Elects New Board Director 292
13.8.5 Jul 31, 2007:
Baxter Announces Quarterly Dividend 292
13.8.6 Mar 13, 2007: Baxter
Declares Additional Share Repurchase Authorization 292
13.8.7 Feb 13,
2007: Baxter Announces Quarterly Dividend 293
13.8.8 Nov 28, 2006: Baxter
Announces Annual Dividend 293
13.8.9 Sep 14, 2006: Baxter Appoints
President, Baxter Latin America 293
13.9 Baxter International Inc.
Pipeline Products 294
13.9.1 Next-Generation Home Hemodialysis Machine
294
13.9.1.1 Product Overview 294
13.9.1.2 Product Description 294
13.9.1.3 Product Status 294
13.9.1.4 Product Milestone 294
14 The
HARTMANN GROUP Company Profile 296
14.1 Company Overview 296
14.2
Business Overview 296
14.2.1 Incontinence Management 296
14.2.2
Operating Theater Management 296
14.2.3 Other GROUP Activities 297
14.2.4 Wound Management 297
14.2.5 Products 298
14.2.6 History 299
14.3 Value Chain Analysis 301
14.3.1 Manufacturing 301
14.3.2 Product
Development 302
14.3.3 Sales and Marketing 302
14.4 SWOT Analysis
303
14.4.1 HARTMANN GROUP Strengths 303
14.4.2 HARTMANN GROUP
Weaknesses 304
14.4.3 HARTMANN GROUP Opportunities 304
14.4.4 HARTMANN
GROUP Threats 305
14.5 Financial and Operational Review 307
14.6
Locations And Subsidiaries 308
14.7 Recent Developments 310
14.7.1 Mar
17, 2008: Hartmann Declares 2007 Results 310
14.7.2 Jan 29, 2008: HARTMANN
Establishes New Subsidiary In Siberia 311
14.7.3 Jan 11, 2008: HARTMANN
Launches New Subsidiary In Ulm 312
14.7.4 Aug 10, 2007: Hartmann Reports
H1 2007 Results 313
15 Regulation System 315
15.1 Medical Equipment
Approval Process 315
15.1.1 Classification 315
15.1.2 Registration and
Conformity Assessment 322
15.2 Advertising 324
15.3 Labeling and
Packaging 325
15.4 Post-market Surveillance 326
15.5 Registration Fee
326
16 Pricing and Reimbursement 334
17 Distribution Structure 335
18 APPENDIX 336
18.1 Global Markets Direct Research Methodology 336
18.2 Coverage 337
18.3 Secondary Research 337
18.4 Primary Research
338
18.5 Models 338
18.6 Forecasts 339
18.7 Expert Panels 339
18.8 Currency Conversion 340
18.9 Contact Us 341
18.10 Disclaimer
341
List of Tables
1.1 List of Tables
Table 1:
Healthcare Infrastructure in Australia, 2004-05 25
Table 2: Healthcare
Personnel in Australia, 2005-06 26
Table 3: Hospital Wards by Specialty in
Australia, 2007 27
Table 4: Doctors by Specialty in Australia, 2007 28
Table 5: Wound Care Management, Australia, Overall Revenues ($ mn), 2000-2012
30
Table 6: Wound Care Management, Australia, Overall Revenues ($ mn),
Historic, 2000-2007 31
Table 7: Wound Care Management, Australia, Overall
Revenues ($ mn), Forecast, 2007-2012 32
Table 8: Wound Care Management,
Australia, Category Revenues ($ mn), 2000-2012 33
Table 9: Wound Care
Management, Australia, Category Revenues ($ mn), Historic, 2000-2007 34
Table 10: Wound Care Management, Australia, Category Revenues ($ mn),
Forecast, 2007-2012 35
Table 11: Wound Care Management, Australia,
Category Volume (Units), 2000-2012 36
Table 12: Wound Care Management,
Australia, Category Volume (Units), Historic, 2000-2007 37
Table 13: Wound
Care Management, Australia, Category Volume (Units), Forecast, 2007-2012
38
Table 14: Wound Care Management, Australia, Company Share by Revenue ($
mn), 2005-2006 39
Table 15: Wound Closure Devices, Australia, Overall
Revenues ($ mn), Historic, 2000-2007 40
Table 16: Wound Closure Devices,
Australia, Overall Revenues ($ mn), Forecast, 2007-2012 41
Table 17: Wound
Closure Devices, Australia, Revenue by Segment ($ mn), Historic, 2000-2007
42
Table 18: Wound Care Management, Australia, Revenue by Segment ($ mn),
Forecast, 2007-2012 43
Table 19: Skin Closure Devices, Australia, Overall
Revenues ($ mn), Historic, 2000-2007 44
Table 20: Skin Closure Devices,
Australia, Overall Revenues ($ mn), Forecast, 2007-2012 45
Table 21:
Hemostats, Australia, Overall Revenues ($ mn), Historic, 2000-2007 46
Table 22: Hemostats, Australia, Overall Revenues ($ mn), Forecast, 2007-2012
47
Table 23: Tissue Sealants, Australia, Overall Revenues ($ mn),
Historic, 2000-2007 48
Table 24: Tissue Sealants, Australia, Overall
Revenues ($ mn), Forecast, 2007-2012 49
Table 25: Wound Care Management,
Australia, Overall Volume (Units), Historic, 2000-2007 50
Table 26: Wound
Care Management, Australia, Overall Volume (Units), Forecast, 2007-2012 51
Table 27: Skin Closure Devices, Australia, Overall Volume (Units), Historic,
2000-2007 52
Table 28: Skin Closure Devices, Australia, Overall Volume
(Units), Forecast, 2007-2012 53
Table 29: Hemostats, Australia, Overall
Volume (Units), Historic, 2000-2007 54
Table 30: Hemostats, Australia,
Overall Volume (Units), Forecast, 2007-2012 55
Table 31: Tissue Sealants,
Australia, Overall Volume (Units), Historic, 2000-2007 56
Table 32: Tissue
Sealants, Australia, Overall Volume (Units), Forecast, 2007-2012 57
Table
33: Hemostats, Australia, Average Price ($), Historic, 2000-2007 58
Table
34: Hemostats, Australia, Average Price ($), Forecast, 2007-2012 59
Table
35: Tissue Sealants, Australia, Average Price ($), Historic, 2000-2007 60
Table 36: Tissue Sealants, Australia, Average Price ($), Forecast, 2007-2012
61
Table 37: Skin Closure Devices, Australia, Average Price ($), Historic,
2000-2007 62
Table 38: Skin Closure Devices, Australia, Average Price ($),
Forecast, 2007-2012 63
Table 39: Wound Closure Devices, Australia,
Distribution Share by Revenue ($ mn), 2005-2006 64
Table 40: Wound Closure
Devices, Australia, Company Share by Revenue ($ mn), 2005-2006 65
Table
41: Ostomy, Australia, Overall Revenues ($ mn), Historic, 2000-2007 66
Table 42: Ostomy, Australia, Overall Revenues ($ mn), Forecast, 2007-2012
67
Table 43: Ostomy, Australia, Overall Volume (Units), Historic,
2000-2007 68
Table 44: Ostomy, Australia, Overall Volume (Units),
Forecast, 2007-2012 69
Table 45: Ostomy, Australia, Average Price ($),
Historic, 2000-2007 70
Table 46: Ostomy, Australia, Average Price ($),
Forecast, 2007-2012 71
Table 47: Ostomy , Australia, Distribution Share by
Revenue ($ mn), 2005-2006 72
Table 48: Ostomy , Australia, Company
Share by Revenue ($ mn), 2005-2006 73
Table 49: Advanced Wound Management,
Australia, Overall Revenues ($ mn), Historic, 2000-2007 74
Table 50:
Advanced Wound Management, Australia, Overall Revenues ($ mn), Forecast,
2007-2012 75
Table 51: Advanced Wound Management, Australia, Overall
Volume (Units), Historic, 2000-2007 76
Table 52: Advanced Wound
Management, Australia, Overall Volume (Units), Forecast, 2007-2012 77
Table 53: Advanced Wound Management, Australia, Average Price ($), Historic,
2000-2007 78
Table 54: Advanced Wound Management, Australia, Average Price
($), Forecast, 2007-2012 79
Table 55: Advanced Wound Management ,
Australia, Distribution Share by Revenue ($ mn), 2005-2006 80
Table 56:
Advanced Wound Management , Australia, Company Share by Revenue ($ mn),
2005-2006 81
Table 57: Traditional Wound Management, Australia, Overall
Revenues ($ mn), Historic, 2000-2007 82
Table 58: Traditional Wound
Management, Australia, Overall Revenues ($ mn), Forecast, 2007-2012 83
Table 59: Traditional Wound Management, Australia, Overall Volume (Units),
Historic, 2000-2007 84
Table 60: Traditional Wound Management, Australia,
Overall Volume (Units), Forecast, 2007-2012 85
Table 61: Traditional Wound
Management, Australia, Average Price ($), Historic, 2000-2007 86
Table 62:
Traditional Wound Management, Australia, Average Price ($), Forecast,
2007-2012 87
Table 63: Traditional Wound Management, Australia,
Distribution Share by Revenue ($ mn), 2005-2006 88
Table 64: Traditional
Wound Management, Australia, Company Share by Revenue ($ mn), 2005-2006 89
Table 65: Compression Therapy, Australia, Overall Revenues ($ mn), Historic,
2000-2007 90
Table 66: Compression Therapy, Australia, Overall Revenues ($
mn), Forecast, 2007-2012 91
Table 67: Compression Therapy, Australia,
Overall Volume (Units), Historic, 2000-2007 92
Table 68: Compression
Therapy, Australia, Overall Volume (Units), Forecast, 2007-2012 93
Table
69: Compression Therapy, Australia, Average Price ($), Historic, 2000-2007
94
Table 70: Compression Therapy, Australia, Average Price ($), Forecast,
2007-2012 95
Table 71: Compression Therapy, Australia, Distribution Share
by Revenue ($ mn), 2005-2006 96
Table 72: Compression Therapy, Australia,
Company Share by Revenue ($ mn), 2005-2006 97
Table 73: Covidien
Ltd./Tyco Healthcare, SWOT Analysis, 2007 106
Table 74: Covidien
Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007 110
Table 75: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million,
2003-2007 111
Table 76: Covidien Ltd./Tyco Healthcare, Other
Locations 112
Table 77: Covidien Ltd./Tyco Healthcare, Subsidiaries
113
Table 78: 3M Company, SWOT Analysis, 2006 144
Table 79:
3M Company, Financial Statements, USD Million, 2002-2006 147
Table 80:
3M Company, Financial and Operational Overview, USD Million, 2002-2006
148
Table 81: 3M Company, Subsidiaries 149
Table 82: Smith &
Nephew Plc, SWOT Analysis, 2006 228
Table 83: Smith & Nephew Plc,
Financial Statements, USD Million, 2002-2006 231
Table 84: Smith &
Nephew Plc, Financial Ratios, USD Million, 2002-2006 232
Table 85:
Smith & Nephew Plc, Other Locations 233
Table 86: Baxter
International Inc., SWOT Analysis, 2006 265
Table 87: Baxter
International Inc., Financial Statements, USD Million, 2002-2006 268
Table
88: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
269
Table 89: Baxter International Inc., Other Locations 270
Table 90: Baxter International Inc., Subsidiaries 271
Table 91:
HARTMANN GROUP, SWOT Analysis, 2006 303
Table 92: HARTMANN GROUP,
Financial Statements, Euro Thousand, 2002-2006 307
Table 93: HARTMANN
GROUP, Financial Ratios, Euro Thousand, 2002-2006 308
Table 94:
HARTMANN GROUP, Subsidiaries 309
Table 95: Conformity Assessment of
Medical Devices based Device Class, in Australia, 2007 324
Table 96: Fee
for Registered Device in Australia, 2007 326
Table 97: Fee for Device
Clinical Trial in Australia, 2007 327
Table 98: Evaluation Fee for High
and Low Level Registration of Medical Device in Australia, 2007 327
Table
99: Evaluation Fee for Variation Registration of Medical Device in Australia,
2007 328
Table 100: Fee for Registration of Listed Devices in Australia,
2007 328
Table 101: Fee for Registration of Listed Devices for Export Only
in Australia, 2007 329
Table 102: Fee for Registration of Included Devices
in Australia, 2007 329
Table 103: Fee for Initial Conformity Assessment of
Medical Device in Australia, 2007 330
Table 104: Fee for Medical Device
Changes Conformity Assessment in Australia, 2007 330
Table 105: Fee for
Medical Device Conformity Assessment Surveillance Audit in Australia, 2007
330
Table 106: Fee for Medical Device Conformity Assessment Review
Certificate in Australia, 2007 331
Table 107: Fee for Initial Conformity
Assessment of Medical Device Components in Australia, 2007 331
Table 108:
Fee for Conformity Assessment of Changes in Medical Device Components in
Australia, 2007 331
Table 109: Fee for Abridged Conformity Assessment of
Medical Device Components in Australia, 2007 332
Table 110: Fee for
Inclusion of Medical Device in the Register in Australia, 2007 332
Table
111: Fee for ARTG Inclusion for Medical Device in Australia, 2007 333
Table 112: Currency Conversion from USD to Local Currency at 2007 Constant
Rate 340
List of Figures
1.1 List of Figures
Figure 1: Total Healthcare Expenditure in Australia, 2000 -- 2005 23
Figure 2: Healthcare Financing Framework in Australia, 2007 24
Figure 3:
Healthcare System in Australia, 2007 29
Figure 4: Wound Care Management,
Australia, Overall Revenues ($ mn), 2000-2012 30
Figure 5: Wound Care
Management, Australia, Overall Revenues ($ mn), Historic, 2000-2007 31
Figure 6: Wound Care Management, Australia, Overall Revenues ($ mn), Forecast,
2007-2012 32
Figure 7: Wound Care Management, Australia, Category Revenues
($ mn), 2000-2012 33
Figure 8: Wound Care Management, Australia, Category
Revenues ($ mn), Historic, 2000-2007 34
Figure 9: Wound Care Management,
Australia, Category Revenues ($ mn), Forecast, 2007-2012 35
Figure 10:
Wound Care Management, Australia, Category Volume (Units), 2000-2012 36
Figure 11: Wound Care Management, Australia, Category Volume (Units),
Historic, 2000-2007 37
Figure 12: Wound Care Management, Australia,
Category Volume (Units), Forecast, 2007-2012 38
Figure 13: Wound Care
Management, Australia, Company Share (%), 2006 39
Figure 14: Wound Closure
Devices, Australia, Overall Revenues ($ mn), Historic, 2000-2007 40
Figure
15: Wound Closure Devices, Australia, Overall Revenues ($ mn), Forecast,
2007-2012 41
Figure 16: Wound Closure Devices, Australia, Revenue by
Segment ($ mn), Historic, 2000-2007 42
Figure 17: Wound Closure Devices,
Australia, Revenue by Segment ($ mn), Forecast, 2007-2012 43
Figure 18:
Skin Closure Devices, Australia, Overall Revenues ($ mn), Historic, 2000-2007
44
Figure 19: Skin Closure Devices, Australia, Overall Revenues ($ mn),
Forecast, 2007-2012 45
Figure 20: Hemostats, Australia, Overall Revenues
($ mn), Historic, 2000-2007 46
Figure 21: Hemostats, Australia, Overall
Revenues ($ mn), Forecast, 2007-2012 47
Figure 22: Tissue Sealants,
Australia, Overall Revenues ($ mn), Historic, 2000-2007 48
Figure 23:
Tissue Sealants, Australia, Overall Revenues ($ mn), Forecast, 2007-2012
49
Figure 24: Wound Care Management, Australia, Overall Volume (Units),
Historic, 2000-2007 50
Figure 25: Wound Care Management, Australia,
Overall Volume (Units), Forecast, 2007-2012 51
Figure 26: Skin Closure
Devices, Australia, Overall Volume (Units), Historic, 2000-2007 52
Figure
27: Skin Closure Devices, Australia, Overall Volume (Units), Forecast,
2007-2012 53
Figure 28: Hemostats, Australia, Overall Volume (Units),
Historic, 2000-2007 54
Figure 29: Hemostats, Australia, Overall Volume
(Units), Forecast, 2007-2012 55
Figure 30: Tissue Sealants, Australia,
Overall Volume (Units), Historic, 2000-2007 56
Figure 31: Tissue Sealants,
Australia, Overall Volume (Units), Forecast, 2007-2012 57
Figure 32:
Hemostats, Australia, Average Price ($), Historic, 2000-2007 58
Figure 33:
Hemostats, Australia, Average Price ($), Forecast, 2007-2012 59
Figure 34:
Tissue Sealants, Australia, Average Price ($), Historic, 2000-2007 60
Figure 35: Tissue Sealants, Australia, Average Price ($), Forecast, 2007-2012
61
Figure 36: Skin Closure Devices, Australia, Average Price ($),
Historic, 2000-2007 62
Figure 37: Skin Closure Devices, Australia, Average
Price ($), Forecast, 2007-2012 63
Figure 38: Wound Closure Devices,
Australia, Distribution Share (%), 2006 64
Figure 39: Wound Closure
Devices, Australia, Company Share (%), 2006 65
Figure 40: Ostomy,
Australia, Overall Revenues ($ mn), Historic, 2000-2007 66
Figure 41:
Ostomy, Australia, Overall Revenues ($ mn), Forecast, 2007-2012 67
Figure
42: Ostomy, Australia, Overall Volume (Units), Historic, 2000-2007 68
Figure 43: Ostomy, Australia, Overall Volume (Units), Forecast, 2007-2012
69
Figure 44: Ostomy, Australia, Average Price ($), Historic, 2000-2007
70
Figure 45: Ostomy, Australia, Average Price ($), Forecast, 2007-2012
71
Figure 46: Ostomy , Australia, Company Share (%), 2006 73
Figure
47: Advanced Wound Management, Australia, Overall Revenues ($ mn), Historic,
2000-2007 74
Figure 48: Advanced Wound Management, Australia, Overall
Revenues ($ mn), Forecast, 2007-2012 75
Figure 49: Advanced Wound
Management, Australia, Overall Volume (Units), Historic, 2000-2007 76
Figure 50: Advanced Wound Management, Australia, Overall Volume (Units),
Forecast, 2007-2012 77
Figure 51: Advanced Wound Management, Australia,
Average Price ($), Historic, 2000-2007 78
Figure 52: Advanced Wound
Management, Australia, Average Price ($), Forecast, 2007-2012 79
Figure
53: Advanced Wound Management , Australia, Distribution Share (%), 2006 80
Figure 54: Advanced Wound Management , Australia, Company Share (%), 2006
81
Figure 55: Traditional Wound Management, Australia, Overall Revenues ($
mn), Historic, 2000-2007 82
Figure 56: Traditional Wound Management,
Australia, Overall Revenues ($ mn), Forecast, 2007-2012 83
Figure 57:
Traditional Wound Management, Australia, Overall Volume (Units), Historic,
2000-2007 84
Figure 58: Traditional Wound Management, Australia, Overall
Volume (Units), Forecast, 2007-2012 85
Figure 59: Traditional Wound
Management, Australia, Average Price ($), Historic, 2000-2007 86
Figure
60: Traditional Wound Management, Australia, Average Price ($), Forecast,
2007-2012 87
Figure 61: Traditional Wound Management, Australia,
Distribution Share (%), 2006 88
Figure 62: Traditional Wound Management,
Australia, Company Share (%), 2006 89
Figure 63: Compression Therapy,
Australia, Overall Revenues ($ mn), Historic, 2000-2007 90
Figure 64:
Compression Therapy, Australia, Overall Revenues ($ mn), Forecast, 2007-2012
91
Figure 65: Compression Therapy, Australia, Overall Volume (Units),
Historic, 2000-2007 92
Figure 66: Compression Therapy, Australia, Overall
Volume (Units), Forecast, 2007-2012 93
Figure 67: Compression Therapy,
Australia, Average Price ($), Historic, 2000-2007 94
Figure 68:
Compression Therapy, Australia, Average Price ($), Forecast, 2007-2012 95
Figure 69: Compression Therapy, Australia, Distribution Share (%), 2006 96
Figure 70: Compression Therapy, Australia, Company Share (%), 2006 97
Figure 71: Covidien Ltd./Tyco Healthcare, Value Chain Analysis 103
Figure 72: 3M Company, Value Chain Analysis 142
Figure 73: Smith
& Nephew Plc, Value Chain Analysis 225
Figure 74: Baxter
International Inc., Value Chain Analysis 263
Figure 75: HARTMANN
GROUP, Value Chain Analysis 301
Figure 76: Classification of Medical
Devices in Australia, 2007 317
Figure 77: Classification of Noninvasive
Devices in Australia, 2007 318
Figure 78: Classification of Invasive
Devices in Australia, 2007 319
Figure 79: Classification of Invasive
Devices in Australia, 2007 320
Figure 80: Classification of Active Devices
in Australia, 2007 321
Figure 81: Classification of Special Medical
Devices in Australia, 2007 322
Figure 82: Conformity Assessment Procedure
for Medical Devices in Australia, 2007 323
Figure 83: Global Markets
Direct Methodology 336
